7 Biotechs With Catalysts in the Next Month
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Ardelyx shares dropped on Friday after the firm announced that the FDA has approved its treatment of irritable bowel syndrome with constipation in adults.
According to the Department of Health and Human Services, most healthy adults should get at least 150 minutes of moderate aerobic exercise or 75 minutes of vigorous aerobic exercise a week. However, a small…
SmileDirectClub shares dropped on Thursday after its initial public offering.
Life science technology company 10X Genomics entered the market with a bang on Thursday in its initial public offering.
Adverum Bio shares dropped sharply on Thursday after the firm announced data from its Optic Phase 1 clinical trial in wet age-related macular degeneration.
Calorie-restricted diets are something of a trend these days. This might mean consuming as little as 1,200 calories a day (the average in the U.S. is 2,745 for males, 1,833 for females). Tests have…
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Roger Ailes, the late, disgraced former chairman and CEO of Fox News — whose downfall was chronicled in the recent HBO mini-series “The Loudest Voice” and is the subject of a forthcoming movie called…
Nutritional supplements often get a bad rap from doctors and nutritional scientists, but a new study — the largest evidence-based review of the subject ever undertaken — suggests that, if nothing else, some supplements…
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Xeris Pharmaceuticals shares were halted briefly on Tuesday after the firm announced that it has received regulatory approval from the FDA for Gvoke, its treatment of severe hypoglycemia in pediatric and adult patients with…
Intra-Cellular Therapies shares dipped on Tuesday after the firm released a disappointing update from the FDA concerning its treatment for schizophrenia.